drugset / Trial / NCT06536101
The Purpose of the Study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407
RandomizedSequentialDouble-blindTreatment
Summary
This study is for the evaluation of the safety, tolerability, PK, PD, and biomarker activity of GIM-407 in healthy volunteers in the absence of any disease-related or potentially confounding factors.
Timeline
- Start
- 2024-09-02
- Primary completion
- 2025-04-05
- Completion
- 2025-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GIM-407 | Unknown | — | Oral |
Indications
No indication recorded.